ILLUMINOX

EUIPO EUIPO 2021 Application withdrawn

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark ILLUMINOX was filed as Word mark on 03/30/2021 at the European Union Intellectual Property Office. The current status of the mark is "Application withdrawn".

Trademark Details Last update: February 8, 2024

Trademark form Word mark
File reference 018442585
Application date March 30, 2021
Publication date April 23, 2021

Trademark owner

Suite 400, 900 Concar Drive
94402 San Mateo
US

Trademark representatives

Prinses Amaliaplein 3 1077 XS Amsterdam NL

Objection / Complaint

06/21/2021: Likelihood of confusion Unfair advantage /detriment to distinctiveness or repute
Applicant
Illumina, Inc.
07/22/2021: Likelihood of confusion
Trademark
Applicant
CRISTALFARMA S.r.l.

goods and services

5 Pharmaceutical preparations for the treatment and prevention of cancer
10 Medical devices for treating and preventing cancer
41 Educational services, namely, providing classes, seminars, and lectures, all in the field of the diagnosis and treatment of cancer; education, providing training in the oncology field
42 Scientific, biological, and medical research; Advancing knowledge and developing new approaches through conducting clinical trials for others; Providing temporary use of on-line non-downloadable software for tracking and storing personal information about the symptoms, side effects, treatment of and experience with an individual's cancer, logging daily actions and results of activity and cognitive tests, and sharing results based on such information
44 Providing information in the field of health care, medical conditions, medicine and pharmaceuticals; Providing medical information on pharmaceuticals and oncology platforms; Providing medical and patient support information in relation to the treatment of cancer; counseling services, namely, medical counseling for patients diagnosed with cancer; information services in the field of diagnosing and treating cancer; Providing online information services, namely, prescription drug information; Providing information in the field of medicine; providing medical information regarding medical conditions and diseases and providing information relating to the health effects of pharmaceuticals; Providing an Internet website featuring information and content about cancer, cancer recovery, cancer treatment, and post-cancer treatment care and survival; providing an online searchable database featuring articles and information about cancer, cancer recovery, cancer treatment, and post-cancer treatment care and survival; Medical diagnostic testing and reporting services; genetic testing for diagnostic and treatment purposes; providing healthcare information regarding cancer drugs and cancer treatment; Providing prescription drug research information by means of providing links to third party websites relating to cancer drugs

ID: 11018442585